US2004033187A1PendingUtilityA1
Bioactive sol-gel derived silica fibers, methods for their preparation and their use
Priority: Dec 1, 1999Filed: Apr 11, 2003Published: Feb 19, 2004
Est. expiryDec 1, 2019(expired)· nominal 20-yr term from priority
C04B 35/6224A61L 27/025C04B 2235/441D01F 9/08A61L 31/028C03B 37/011C04B 35/624C03B 37/10
38
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to bioactive sol-gel derived silica fibers, methods for their preparation, an implantable device comprising said fibers and the use of said device for tissue guiding or bone repair.
Claims
exact text as granted — not AI-modified1 . A method for the preparation of a bioactive sol-gel derived silica fiber, said method comprising spinning the fiber from a silica sol wherein the starting point of the spinning process corresponds to a sol viscosity of at least 2000 cP, followed by i) heat treating or ii) aging of the fiber.
2 . The method according to claim 1 wherein the viscosity is at least 3000 cP.
3 . The method according to claim 1 wherein the fiber is heat treated for a sufficient period of time in a temperature in the range 150 to 250° C.
4 . The method according to claim 3 wherein the temperature range is 150 to 200° C., preferably about 175° C.
5 . The method according to claim 2 wherein the fiber is heat treated for a sufficient period of time in a temperature in the range 150 to 250° C.
6 . The method according to claim 5 wherein the temperature range is 150 to 200° C., preferably about 175° C.
7 . The method according to claim 1 wherein the fiber is aged for about 2 weeks to 5 months.
8 . The method according to claim 7 wherein the fiber is aged for about 3 to 5 months.
9 . The method according to claim 2 wherein the fiber is aged for about 2 weeks to 5 months.
10 . The method according to claim 9 wherein the fiber is aged for about 3 to 5 months.
11 . A bioactive sol-gel derived silica fiber spun from a sol at a starting point of the spinning process corresponding to a sol viscosity of at least 2000 cP, after which said fiber has been subjected to i) heat treatment or ii) aging.
12 . The fiber according to claim 11 wherein said viscosity is at least 3000 cP.
13 . The fiber according to claim 11 wherein said fiber has been heat treated for a sufficient period of time in a temperature in the range 150 to 250° C.
14 . The fiber according to claim 13 , said fiber having been heat treated in the temperature range 150 to 200° C., preferably about 175° C.
15 . The fiber according to claim 12 wherein said fiber has been heat treated for a sufficient period of time in a temperature in the range 150 to 250° C.
16 . The fiber according to claim 15 , said fiber having been heat treated in the temperature range 150 to 200° C., preferably about 175° C.
17 . The fiber according to claim 11 wherein said fiber has been aged for about 2 weeks to 5 months.
18 . The fiber according to claim 17 wherein said fiber has been aged for about 3 to 5 months.
19 . The fiber according to claim 12 wherein said fiber has been aged for about 2 weeks to 5 months.
20 . The fiber according to claim 19 wherein said fiber is aged for about 3 to 5 months.
21 . The fiber according to any of the claims 11 to 20 wherein said fiber also comprises a biologically active agent.
22 . An implantable device comprising a fiber according to any one of the claims 11 to 20 .
23 . An implantable device comprising a mixture of two or more kinds of fibers according to any one of the claims 11 to 20 .
24 . The device according to claim 22 in the form or a woven or non-woven mat, a knitted fabric or a braided cord.
25 . The device according to claim 23 in the form or a woven or non-woven mat, a knitted fabric or a braided cord.
26 . An implantable device comprising a fiber according to a any of the claims 11 to 20 wherein said fiber also comprises a biologically active agent.
27 . An implantable device comprising a mixture of two or more kinds of fibers according to any of the claims 11 to 20 , wherein one of more kinds of fibers also contain a biologically active agent.
28 . A method of using a device according to claim 22 for tissue guiding or bone repair.
29 . A method of using a device according to claim 26 for tissue guiding or bone repair.Join the waitlist — get patent alerts
Track US2004033187A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.